Impact of MICA-129 mismatch on HSCT outcomes: Evidence from a large European cohort and meta-analysis
: Nihtilä, Julia; Tammi, Silja; Salmenniemi, Urpu; Itälä-Remes, Maija; Crossland, Rachel; Gallardo, David; Bieniaszewska, Maria; Giebel, Sebastian; Bogunia-Kubik, Katarzyna; Hyvärinen, Kati; Partanen, Jukka; Ritari, Jarmo
Publisher: Elsevier BV
: 2025
Transplantation and cellular therapy
: 31
: 12
: 954.e1
: 954.e4
: 2666-6375
: 2666-6367
DOI: https://doi.org/10.1016/j.jtct.2025.08.023
: https://doi.org/10.1016/j.jtct.2025.08.023
: https://research.utu.fi/converis/portal/detail/Publication/500170489
:
This study was supported by research grants from Cancer Foundation Finland, VTR funding from the Government of Finland to the Blood Service, COST Eurograft Action CA17138, Orion Research Foundation sr (JN), Blood Disease Research Foundation (JN), Ida Montini Foundation sr (JN), University of Helsinki (JN). National Institute of Health Carlos III 428 (ISCIII) (Spain) co-funded by the European Union (grants number PI17/00815 and PI20/01353) (DG). This study was performed in collaboration with the Polish Adult Leukemia Group and supported in part by the National Science Centre (Poland) (grant No. 2018/31/B/NZ2/03065) (MB, SG and K B-K).
